Ameliorative effects of agomelatine against doxorubicin-induced hepatotoxicity
Abstract Drug-induced hepatotoxicity is a significant impediment to the use of doxorubicin, a commonly employed chemotherapeutic agent with established efficacy in cancer treatment. The present study aimed to determine the potential protective effects of agomelatine against doxorubicin hepatotoxicit...
Saved in:
| Main Authors: | Hasan Basri Savas, Mehmet Enes Sozen, Gokhan Cuce, Tuba Batur |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Pharmacology and Toxicology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40360-025-00988-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histopathological Evaluation of Erythropoietin's Protective Effect Against Doxorubicin-Induced Hepatotoxicity
by: Zeena Jasim Saddam, et al.
Published: (2025-05-01) -
Fluoxetine and agomelatine mitigate anhedonic and hepatic changes in chronic restraint stress rat model
by: Wedad S. Sarawi, et al.
Published: (2025-07-01) -
Protective effects of naringin against oxidative stress, inflammation, apoptosis, and DNA damage in rats with doxorubicin-induced hepatotoxicity
by: Pelin Durukan Azman, et al.
Published: (2025-07-01) -
The protective role of melatonin and agomelatine against oxidative stress following laparoscopic ovariectomy in dogs
by: S Azizi, et al.
Published: (2025-03-01) -
Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats
by: Maha Abdullah Alwaili, et al.
Published: (2024-12-01)